M&A Analysis
Most acquisitions destroy value, and they fail not on the spreadsheet but on the thesis and the integration. The costly failure this skill prevents is the deal that "works" only because unhaircut synergies were stacked until the price looked justified. Judge the deal on strategy first and synergies second, and write the walk-away price before anyone falls in love.
Inputs to collect
- The target: what it does, revenue and growth, headcount, ownership.
- The acquirer's strategy: the plan the deal is supposed to serve - in writing, not implied.
- Price expectations: asking price or range, last financing valuation, comparable transactions if known.
- Claimed synergies, itemized and separated into cost and revenue, with whoever claimed them named.
- Key people and customers: founder/team dependence, top-customer concentration.
- If any input is a guess, label it a guess and carry it through the scorecard as such.
Operating procedure
Step 1: Write the thesis in one sentence
Before any model, name the single reason for the deal:
- Capability - buy what would take too long to build (team, tech, IP).
- Market access - buy customers, geography, or a channel.
- Consolidation - buy a competitor for scale or pricing power.
- Defensive - keep an asset out of a rival's hands.
A deal that cleanly fits more than one is rare; a deal that fits none is a vanity acquisition. Every subsequent judgment tests against this sentence. If the thesis changes when the price is challenged, that is a red flag, not a refinement.
Step 2: Test strategic fit
- Does the target accelerate the existing strategy, or distract from it?
- Cultural and operating-model fit - the most common silent killer. A bottom-up engineering culture absorbed into a top-down sales machine loses the people the thesis depends on.
- Force the build vs buy vs partner comparison honestly: is acquisition genuinely the best path, or the one that flatters egos? Price the build alternative (time and hiring) so the premium being paid for speed is explicit.
Step 3: Build the synergy bridge with mandatory haircuts
Separate synergies and discount them by type - these haircuts are the practitioner baseline, not pessimism:
- Cost synergies (overlapping functions, infrastructure): the more reliable kind - still haircut 20-30% for execution risk.
- Revenue synergies (cross-sell, bundling, pricing): notoriously overestimated - haircut 50% or more, and push the realization timeline out; cross-sell that "starts in quarter one" starts in year two.
- Dis-synergies must be netted out: customer churn triggered by the deal, attrition of key staff, and integration cost and distraction. Integration cost realism: one-time integration costs routinely run 1-3x the annual cost-synergy number - a bridge that omits them is fiction.
The output is a synergy bridge: standalone value → + haircut cost synergies → + haircut, delayed revenue synergies → − dis-synergies and integration costs → value to the acquirer.
Step 4: Value and set the walk-away price
- Anchor on a standalone DCF of the target, then add the risk-adjusted synergy bridge - never the raw claimed synergies.
- Cross-check with comparable transaction multiples and the target's last financing.
- Write down the walk-away price and the reason before negotiation begins. A walk-away set during negotiation is a rationalization.
- Use structure to de-risk: earn-outs tie payment to results the seller controls; retention packages align the people the thesis depends on.
Step 5: Plan integration before signing
The deal closes; the value is realized or lost in the next 12 months.
- Name the integration owner before signing - a deal with no owner has no plan.
- Identify the 5-10 people whose departure would break the thesis; build retention for them specifically, not a blanket program.
- Decide integration depth deliberately: full absorption vs run-it-separately. A mismatch here (absorbing a culture-dependent team, or leaving a cost-synergy deal unintegrated) is a frequent failure mode.
- Plan the first-100-days communication for both customer bases.
Step 6: Score the deal
Fill the screening scorecard and read the verdict rule at the bottom.
Worked artifact: screening scorecard
Score each dimension 1 (deal-breaking) to 5 (strong). Example: a $60M acquisition of a 40-person analytics company on a capability thesis.
| Dimension |
Score |
Evidence |
| Thesis clarity (one sentence, one type) |
4 |
Capability: ML team + deployed pipeline; 3+ yrs to build in-house |
| Strategic fit / no distraction |
4 |
Directly serves the stated data-product roadmap |
| Cultural / operating-model fit |
2 |
Remote-first 40-person team into RTO 2,000-person org; unaddressed |
| Synergy quality after haircuts |
3 |
Deal clears DCF + cost synergies at −25%; revenue synergies (−50%, year-2 start) are upside, not needed |
| Price vs walk-away |
3 |
Ask $60M; walk-away written at $52M vs standalone DCF $38M + bridge $16M |
| Key-person risk / retention |
2 |
6 critical engineers, no retention packages yet |
| Customer concentration |
4 |
Largest customer 11% of revenue |
| Integration owner and plan |
1 |
No owner named |
Verdict rule: any dimension at 1 blocks signing until fixed; three or more dimensions at 2 or below means renegotiate or pass. This deal: fix the integration owner and retention packages before LOI, and address the culture plan - the price is defensible but the execution risk is not yet.
Deliverable
Produce a deal memo containing: the one-line thesis, the strategic-fit assessment with the build-alternative priced, the risk-adjusted synergy bridge showing every haircut, valuation with the written walk-away price, the integration plan with a named owner and named retention targets, the filled screening scorecard, and the top three risks with mitigations.
Do NOT
- Do not accept synergies at face value - unhaircut synergies are the mechanism by which every overpriced deal gets justified.
- Do not approve a deal where synergies are needed to justify the price; if the deal only works when everything goes right, it does not work.
- Do not skip dis-synergies - deal-driven customer churn and key-staff attrition are real line items, not footnotes.
- Do not sign with founder or key-team flight risk and no retention plan.
- Do not let the thesis mutate to fit the price; a moving thesis is the tell of a deal being rationalized.
- Do not defer naming the integration owner until after close - that is how the first 100 days get lost.
Quality bar
- The thesis is one sentence, one type, and every scorecard row cites evidence against it.
- Every synergy line shows its haircut and its realization timeline; integration costs appear as a negative line.
- The walk-away price exists in writing, dated before negotiation.
- The memo would let a board member reconstruct why the price is fair without asking a single follow-up.
Escalation
This is analysis, not legal, tax, or accounting advice - deal structuring, regulatory clearance, and definitive agreements require M&A counsel and tax advisors. Once a deal moves past screening, run diligence with due-diligence-checklist; test the combined entity's durability with competitive-moat.
1---2name: m-a-analysis3description: Structures an acquisition case - one-line thesis, strategic-fit test, risk-haircut synergy bridge with cost synergies cut 20-30% and revenue synergies cut 50%+, valuation with a written walk-away price, and integration risk - into a screening scorecard and deal memo. Use when someone asks "should we buy this company", "evaluate this acquisition target", "are these synergy numbers real", "what would we pay for them", or is preparing a board memo on a deal. Do NOT use for building the diligence request list and workstream tracker once a deal is moving - use due-diligence-checklist instead; for assessing whether the combined business has a durable advantage, pair with competitive-moat.4---56# M&A Analysis78Most acquisitions destroy value, and they fail not on the spreadsheet but on the thesis and the integration. The costly failure this skill prevents is the deal that "works" only because unhaircut synergies were stacked until the price looked justified. Judge the deal on strategy first and synergies second, and write the walk-away price before anyone falls in love.910## Inputs to collect11121. **The target**: what it does, revenue and growth, headcount, ownership.132. **The acquirer's strategy**: the plan the deal is supposed to serve - in writing, not implied.143. **Price expectations**: asking price or range, last financing valuation, comparable transactions if known.154. **Claimed synergies**, itemized and separated into cost and revenue, with whoever claimed them named.165. **Key people and customers**: founder/team dependence, top-customer concentration.176. If any input is a guess, label it a guess and carry it through the scorecard as such.1819## Operating procedure2021### Step 1: Write the thesis in one sentence2223Before any model, name the single reason for the deal:2425- **Capability** - buy what would take too long to build (team, tech, IP).26- **Market access** - buy customers, geography, or a channel.27- **Consolidation** - buy a competitor for scale or pricing power.28- **Defensive** - keep an asset out of a rival's hands.2930A deal that cleanly fits more than one is rare; a deal that fits none is a vanity acquisition. Every subsequent judgment tests against this sentence. If the thesis changes when the price is challenged, that is a red flag, not a refinement.3132### Step 2: Test strategic fit3334- Does the target accelerate the existing strategy, or distract from it?35- Cultural and operating-model fit - the most common silent killer. A bottom-up engineering culture absorbed into a top-down sales machine loses the people the thesis depends on.36- Force the build vs buy vs partner comparison honestly: is acquisition genuinely the best path, or the one that flatters egos? Price the build alternative (time and hiring) so the premium being paid for speed is explicit.3738### Step 3: Build the synergy bridge with mandatory haircuts3940Separate synergies and discount them by type - these haircuts are the practitioner baseline, not pessimism:4142- **Cost synergies** (overlapping functions, infrastructure): the more reliable kind - still haircut **20-30%** for execution risk.43- **Revenue synergies** (cross-sell, bundling, pricing): notoriously overestimated - haircut **50% or more**, and push the realization timeline out; cross-sell that "starts in quarter one" starts in year two.44- **Dis-synergies must be netted out**: customer churn triggered by the deal, attrition of key staff, and integration cost and distraction. Integration cost realism: one-time integration costs routinely run 1-3x the annual cost-synergy number - a bridge that omits them is fiction.4546The output is a synergy bridge: standalone value → + haircut cost synergies → + haircut, delayed revenue synergies → − dis-synergies and integration costs → value to the acquirer.4748### Step 4: Value and set the walk-away price4950- Anchor on a standalone DCF of the target, then add the risk-adjusted synergy bridge - never the raw claimed synergies.51- Cross-check with comparable transaction multiples and the target's last financing.52- **Write down the walk-away price and the reason before negotiation begins.** A walk-away set during negotiation is a rationalization.53- Use structure to de-risk: earn-outs tie payment to results the seller controls; retention packages align the people the thesis depends on.5455### Step 5: Plan integration before signing5657The deal closes; the value is realized or lost in the next 12 months.5859- Name the integration owner before signing - a deal with no owner has no plan.60- Identify the 5-10 people whose departure would break the thesis; build retention for them specifically, not a blanket program.61- Decide integration depth deliberately: full absorption vs run-it-separately. A mismatch here (absorbing a culture-dependent team, or leaving a cost-synergy deal unintegrated) is a frequent failure mode.62- Plan the first-100-days communication for both customer bases.6364### Step 6: Score the deal6566Fill the screening scorecard and read the verdict rule at the bottom.6768## Worked artifact: screening scorecard6970Score each dimension 1 (deal-breaking) to 5 (strong). Example: a $60M acquisition of a 40-person analytics company on a capability thesis.7172| Dimension | Score | Evidence |73|---|---|---|74| Thesis clarity (one sentence, one type) | 4 | Capability: ML team + deployed pipeline; 3+ yrs to build in-house |75| Strategic fit / no distraction | 4 | Directly serves the stated data-product roadmap |76| Cultural / operating-model fit | 2 | Remote-first 40-person team into RTO 2,000-person org; unaddressed |77| Synergy quality after haircuts | 3 | Deal clears DCF + cost synergies at −25%; revenue synergies (−50%, year-2 start) are upside, not needed |78| Price vs walk-away | 3 | Ask $60M; walk-away written at $52M vs standalone DCF $38M + bridge $16M |79| Key-person risk / retention | 2 | 6 critical engineers, no retention packages yet |80| Customer concentration | 4 | Largest customer 11% of revenue |81| Integration owner and plan | 1 | No owner named |8283**Verdict rule**: any dimension at 1 blocks signing until fixed; three or more dimensions at 2 or below means renegotiate or pass. This deal: fix the integration owner and retention packages before LOI, and address the culture plan - the price is defensible but the execution risk is not yet.8485## Deliverable8687Produce a deal memo containing: the one-line thesis, the strategic-fit assessment with the build-alternative priced, the risk-adjusted synergy bridge showing every haircut, valuation with the written walk-away price, the integration plan with a named owner and named retention targets, the filled screening scorecard, and the top three risks with mitigations.8889## Do NOT9091- Do not accept synergies at face value - unhaircut synergies are the mechanism by which every overpriced deal gets justified.92- Do not approve a deal where synergies are needed to justify the price; if the deal only works when everything goes right, it does not work.93- Do not skip dis-synergies - deal-driven customer churn and key-staff attrition are real line items, not footnotes.94- Do not sign with founder or key-team flight risk and no retention plan.95- Do not let the thesis mutate to fit the price; a moving thesis is the tell of a deal being rationalized.96- Do not defer naming the integration owner until after close - that is how the first 100 days get lost.9798## Quality bar99100- The thesis is one sentence, one type, and every scorecard row cites evidence against it.101- Every synergy line shows its haircut and its realization timeline; integration costs appear as a negative line.102- The walk-away price exists in writing, dated before negotiation.103- The memo would let a board member reconstruct why the price is fair without asking a single follow-up.104105## Escalation106107This is analysis, not legal, tax, or accounting advice - deal structuring, regulatory clearance, and definitive agreements require M&A counsel and tax advisors. Once a deal moves past screening, run diligence with due-diligence-checklist; test the combined entity's durability with competitive-moat.
SkillMedev